Legend's Lymphoma Drug on Hold After Patient Reaction
Adverse Events, CAR-T Therapy, CD4+ Cells, Clinical Trials, FDA, MD Anderson Cancer Center, R&D, T-Cell Lymphoma, T-Cells
Legend Biotech's clinical trial of the company's candidate drug for relapsed or refractory T-cell lymphoma was placed on hold effective February 11 after some issues were raised on the first patient dosed.
February 16, 2022 /by BioSpace
https://www.pharmalive.com/wp-content/uploads/2022/02/Legends-Lymphoma-Drug-on-Hold-After-Patient-Reaction-BioSpace-2-16-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-02-16 14:18:002022-02-16 15:24:29Legend's Lymphoma Drug on Hold After Patient Reaction
New Research Explains Why Cancer Cells Often Spread to the Lymph Nodes First
Cancer Cells, CD4+ Cells, Immunotherapies, Lymph Nodes, Medical Journals, Melanoma Cells, Nature, Organs, R&D, Tumors
A study published in the scientific journal Nature explains why certain kinds of cancer cells often spread to the lymph nodes before various organs within the body.
August 24, 2020 /by BioSpace
https://www.pharmalive.com/wp-content/uploads/2020/08/New-Research-Explains-Why-Cancer-Cells-Often-Spread-to-the-Lymph-Nodes-First-BioSpace-8-24-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-08-24 11:58:142020-08-25 13:07:37New Research Explains Why Cancer Cells Often Spread to the Lymph Nodes First
GentiBio Launches with $20 Million Seed Funding from Novartis and Others
Business, CD4+ Cells, Company Launches, Immune Cells, Licensing, Partnerships, Science Translational Medicine, Seed Funding, T-Cells, Therapeutics
GentiBio closed on a $20 million seed funding led by OrbiMed, Novartis Venture Fund and RA Capital Management. The company also announced exclusive licensing partnerships with Seattle Children's Research Institute, Benaroya Research Institute at Virginia Mason (BRK), and MIGAL Galilee Research Institute (MIGAL).
August 5, 2020 /by Andrew Humphreys
https://www.pharmalive.com/wp-content/uploads/2020/08/GentiBio-Launches-with-20-Million-Seed-Funding-from-Novartis-and-Others-BioSpace-8-5-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-08-05 11:55:082020-08-05 14:00:03GentiBio Launches with $20 Million Seed Funding from Novartis and Others